Ondrej Fiala, P2.11-047: Sequential treatment with erlotinib and pemetrexed in pretreated patients with lung adenocarcinoma Poster Session 2 - NSCLC Novel Therapies
Sydney, NSW Australia - WCLC 2013: Interviews with Dr. Tony Mok and Dr. Galetta at the the World Conference on Lung Cancer meeting sponsored by the International Association for the Study of Lung Cancer (IASLC) here today, Tuesday, October 29, 2013. More than 5,000 physicians, researchers, health care professionals, cancer survivors and patient advocates are gathered here for WCLC at the Sydney Convention Center which highlights the latest findings in lung cancer research from basic through clinical and epidemiological studies. Date: Tuesday, October 29, 2013 Photo by © MedMeetingImages/Todd Buchanan 2013 Technical Questions: email@example.com; Phone: 612-226-5154.
Poster Session 2 NSCLC Novel Therapies Ondrej Fiala P2.110413WCLC02208